• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH CREATININE; ALKALINE PICRATE, COLORIMETRY, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH CREATININE; ALKALINE PICRATE, COLORIMETRY, CREATININE Back to Search Results
Model Number 3L81-23
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/04/2022
Type of Reportable Event Malfunction
Event or Problem Description
The customer observed falsely elevated creatinine results generated on the architect c4000 processing module for one sample.The following data was provided: sid (b)(6) initial and repeat results = 7.76 mg/dl, a new sample was collected which generated an initial result of 0.854 mg/dl and repeat result of 0.887 mg/dl no impact to patient management was reported.
 
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Additional Manufacturer Narrative
The complaint investigation for falsely elevated creatinine results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and field data review.Return testing was not completed as returns were not available.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot 97127un21 and the complaint issue.The overall performance of creatinine was reviewed using field data from customers worldwide.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for lot number 97127un21 is within the established control limits.Therefore, no unusual reagent lot performance was identified.Labeling was reviewed and found to be adequate.Based on our investigation, no systemic issue or deficiency with the creatinine reagent for lot 97127un21 was identified.
 
Event or Problem Description
The customer observed falsely elevated creatinine results generated on the architect c4000 processing module for one sample.The following data was provided: sid (b)(6) initial and repeat results = 7.76 mg/dl, a new sample was collected which generated an initial result of 0.854 mg/dl and repeat result of 0.887 mg/dl no impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE
Common Device Name
ALKALINE PICRATE, COLORIMETRY, CREATININE
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key14463356
Report Number3002809144-2022-00172
Device Sequence Number17269069
Product Code CGX
UDI-Device Identifier00380740161552
UDI-Public00380740161552
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K083809
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/17/2022
Device Model Number3L81-23
Device Catalogue Number03L81-23
Device Lot Number97127UN21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/04/2022
Supplement Date Received by Manufacturer06/29/2022
Initial Report FDA Received Date05/20/2022
Supplement Report FDA Received Date07/03/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/24/2021
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C4000 INTGR, 02P24-40, C402703; ARC C4000 INTGR, 02P24-40, C402703
Patient SexUnknown
-
-